Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial. Brightling CE, Nair P, Cousins DJ, Louis R, et al. N Engl J Med 2021;385:1669-1679.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brightling CE, Nair P, Cousins DJ, Louis R, et al. Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial. N Engl J Med 2021;385:1669-1679.
PMID: 34706172